Verona Pharma Plc (DELISTED) (VRNA:DL)
106.91
0.00 (0.00%)
USD |
NASDAQ |
Oct 16, 16:00
Verona Pharma Enterprise Value : 9.054B for Oct. 16, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Merck & Co., Inc. | 326.63B |
| AstraZeneca PLC | 340.50B |
| GSK Plc | 138.12B |
| Haleon Plc | -- |
| Adaptimmune Therapeutics Plc | 25.53M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 12.06M |
| Revenue (Quarterly) | 104.36M |
| Total Expenses (Quarterly) | 92.30M |
| EPS Diluted (Quarterly) | 0.1327 |
| Gross Profit Margin (Quarterly) | 95.10% |
| Profit Margin (Quarterly) | 11.56% |
| Earnings Yield | -0.96% |
| Normalized Earnings Yield | -0.9294 |